Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome

A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia

NCT00796783 ·Status: TERMINATED

A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months

NCT07126262 ·Status: RECRUITING ·Phase: PHASE2

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

NCT03604198 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients

NCT00097513 ·Status: COMPLETED

Treatment for Endogenous Cushing's Syndrome

NCT01838551 ·Status: COMPLETED ·Phase: PHASE3

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

NCT00001595 ·Status: RECRUITING

Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

NCT02968004 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Less Than 2 Years Old

NCT07187375 ·Status: RECRUITING ·Phase: PHASE2

Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease

NCT01915303 ·Status: TERMINATED ·Phase: PHASE2

Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study

NCT03709381 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm

NCT00163189 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty

NCT01467882 ·Status: COMPLETED ·Phase: PHASE3

Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia

NCT00140413 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome

NCT03697109 ·Status: COMPLETED ·Phase: PHASE3

Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome

NCT02468193 ·Status: COMPLETED ·Phase: PHASE2

Mifepristone in Children With Refractory Cushing's Disease

NCT01925092 ·Status: WITHDRAWN ·Phase: PHASE3

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

NCT06382155 ·Status: RECRUITING ·Phase: PHASE2

Osilodrostat for the Treatment of Non-Cushing's Disease Cushing's Syndrome

NCT05633953 ·Status: COMPLETED

Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome

NCT01371565 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors

NCT07335315 ·Status: RECRUITING

Cushing's Syndrome Before and After Treatment (CORRECT)

NCT05521529 ·Status: RECRUITING

Long Term Post Operative Follow-Up of Cushing Syndrome

NCT00029952 ·Status: COMPLETED

Efficacy Study of Recombinant Growth Hormone on Muscle Function in Children Long-term Treated With Glucocorticoid

NCT00813189 ·Status: COMPLETED ·Phase: PHASE3

Long-term Cardiovascular Risk in Cured Cushing's Patients

NCT00881283 ·Status: TERMINATED

National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nutropin Depot, and Protropin

NCT00097539 ·Status: COMPLETED